36324416|t|What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
36324416|a| Controversial registration of aducanumab for Alzheimer's Disease Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular cognitive disorders The studies may give detailed phenotyping data that may lead to knowledge of targets for treatments of patients with vascular cognitive disorders.
36324416	10	20	aducanumab	Chemical	MESH:C000600266
36324416	34	53	Alzheimer's disease	Disease	MESH:D000544
36324416	75	103	vascular cognitive disorders	Disease	MESH:D003072
36324416	136	146	aducanumab	Chemical	MESH:C000600266
36324416	151	170	Alzheimer's Disease	Disease	MESH:D000544
36324416	171	181	Aducanumab	Chemical	MESH:C000600266
36324416	307	332	cerebrovascular pathology	Disease	MESH:D002561
36324416	382	410	vascular cognitive disorders	Disease	MESH:D003072
36324416	514	522	patients	Species	9606
36324416	528	556	vascular cognitive disorders	Disease	MESH:D003072
36324416	Association	MESH:C000600266	MESH:D003072
36324416	Negative_Correlation	MESH:C000600266	MESH:D000544

